JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v7i2.4769ArticleClinical Significance and Levels of NLRP3, MUC5AC, and MUC5B in Asthmahttps://artdesignp.com/journal/JCNR/7/2/10.26689/jcnr.v7i2.4769YaoYang,LiSiyu,ZhouJing,TianYao,ZhangJinzhao,LiYaming,WangShengyu2023722023-03-29Objective: To explore the role of NLRP3 in mucus hypersecretion in asthmatic patients. Methods: From January 2020 to June 2022, 90 patients with asthma and 60 healthy patients under the Department of Pulmonary and Critical Care Medicine of the First Affiliated Hospital of Xi’an Medical University were selected. Immunohistochemistry and enzyme-linked immunosorbent assay were performed. NLRP3 inflammasome and mucins MUC5AC and MUC5B levels in lung tissue and sputum were detected. Results: Compared to the healthy control group, the asthma group had significantly higher sputum MUC5A (20.12 ± 5 .07 versus 36.21 ± 6.13) and NLRP3 (72.31 ± 15.13 versus 119.21 ± 31.21) levels (P < 0.05) but lower MUC5B levels (1.35 ± 0.12 versus 0.53 ± 0.11, P < 0.05). Immunohistochemistry showed that NLRP3, MUC5AC, and MUC5B expressions were consistent with the sputum results. Conclusion: NLRP3 and MUC5AC levels are significantly increased in asthmatic patients, whereas MUC5B levels are reduced in these patients. They can be used as targets for the diagnosis and treatment of asthma.

Park SC, Kim H, Bak Y, et al., 2020, An Alternative Dendritic Cell-Induced Murine Model of Asthma Exhibiting a Robust Th2/Th17-Skewed Response. Allergy Asthma Immunol Res, 12(3): 537–555.

Jia Z, Bao K, Wei P, et al., 2020, EGFR Activation-Induced Decreases in Claudin1 Promote MUC5AC Expression and Exacerbate Asthma in Mice. Mucosal Immunol, 14(1): 125–134. https://doi.org/10.1038/s41385-020-0272-z

Hokoop PJ, Chavannes NH, 2020, Asthma Phenotypes in Primary Care. NPJ Prim Care Respir Med, 30(1): 13–19.

Widhianingsih D, Koontongkaew S, 2020, Enhancement of Cariogenic Virulence Properties of Dental Plaque in Asthmatics. J Asthma, 6: 1–10.

Aghasafari P, George U, Pidaparti R, 2019, A Review of Inflammatory Mechanism in Airway Diseases. Inflamm Res, 68(1): 59–74.

Yoshida Y, Takaku Y, Nakamoto Y, et al., 2020, Changes in Airway Diameter and Mucus Plugs in Patients with Asthma Exacerbation. PLoS One, 15(2): e0229238.

Dunican EM, Watchorn DC, Fahy JV, 2018, Autopsy and Imaging Studies of Mucus in Asthma. Lessons Learned about Disease Mechanisms and the Role of Mucus in Airflow Obstruction. Ann Am Thorac Soc, 15(Suppl 3): S184–S191.

Zhu C, Zhang L, Liu Z, et al., 2020, Atractylenolide III Reduces NLRP3 Inflammasome Activation and Th1/Th2 Imbalances in Both In Vitro and In Vivo Models of Asthma. Clin Exp Pharmacol Physiol, 47(8): 1360–1367. https://doi.org/10.1111/1440-1681.13306

Kim SR, Park HJ, Lee KB, et al., 2020, Epithelial PI3K-? Promotes House Dust Mite-Induced Allergic Asthma in NLRP3 Inflammasome-Dependent and -Independent Manners. Allergy Asthma Immunol Res, 12(2): 338–358.

Ince D, Lucas TM, Malaker SA, 2022, Current Strategies for Characterization of Mucin-Domain Glycoproteins. Curr Opin Chem Biol, 69: 102174.

Zhang Y, Sun L, Lei C, et al., 2022, A Sweet Warning: Mucin-Type O-Glycans in Cancer. Cells, 11(22): 3666.

Radicioni G, Ceppe A, Ford AA, et al., 2021, Airway Mucin MUC5AC and MUC5B Concentrations and the Initiation and Progression of Chronic Obstructive Pulmonary Disease: An Analysis of the SPIROMICS Cohort. Lancet Respir Med, 9(11): 1241–1254.

Chen X, Yang J, Shen H, et al., 2021, Muc5ac Production Inhibited by Decreased lncRNA H19 via PI3K/Akt/NF-kB in Asthma. J Asthma Allergy, 14: 1033–1043.

Henry KE, Shaffer TM, et al., 2021, Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer. J Nucl Med, 62(10): 1384–1390.

Lin YH, Zhu LY, Yang YQ, et al., 2021, Resveratrol Inhibits MUC5AC Expression by Regulating SPDEF in Lung Cancer Cells. Phytomedicine, 89: 153601.

Theofani E, Semitekolou M, Samitas K, et al., 2022, TFEB Signaling Attenuates NLRP3-Driven Inflammatory Responses in Severe Asthma. Allergy, 77(7): 2131–2146.

Kim RY, Pinkerton JW, Essilfie AT, et al., 2017, Role for NLRP3 Inflammasome-Mediated, IL-1?-Dependent Responses in Severe, Steroid-Resistant Asthma. Am J Respir Crit Care Med, 196(3): 283–297.